Global Patient Derived Xenograft/PDX Models Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
SKU ID :GIR-12419185 | Published Date: 11-Oct-2018 | No. of pages: 131Description
TOC
Table of Contents
1 Patient Derived Xenograft/PDX Models Market Overview
1.1 Product Overview and Scope of Patient Derived Xenograft/PDX Models
1.2 Classification of Patient Derived Xenograft/PDX Models by Types
1.2.1 Global Patient Derived Xenograft/PDX Models Revenue Comparison by Types (2017-2023)
1.2.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Types in 2017
1.2.3 Mice Models
1.2.4 Rat Models
1.3 Global Patient Derived Xenograft/PDX Models Market by Application
1.3.1 Global Patient Derived Xenograft/PDX Models Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pre-clinical Drug Development and Basic Cancer Research
1.3.3 Biomarker Analysis
1.4 Global Patient Derived Xenograft/PDX Models Market by Regions
1.4.1 Global Patient Derived Xenograft/PDX Models Market Size (Million ) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)
1.5 Global Market Size of Patient Derived Xenograft/PDX Models (2013-2023)
2 Manufacturers Profiles
2.1 Crown Bioscience
2.1.1 Business Overview
2.1.2 Patient Derived Xenograft/PDX Models Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.2 The Jackson Laboratory
2.2.1 Business Overview
2.2.2 Patient Derived Xenograft/PDX Models Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.3 Champions Oncology
2.3.1 Business Overview
2.3.2 Patient Derived Xenograft/PDX Models Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.4 Charles River Laboratories
2.4.1 Business Overview
2.4.2 Patient Derived Xenograft/PDX Models Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.5 WuXi Apptec
2.5.1 Business Overview
2.5.2 Patient Derived Xenograft/PDX Models Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.6 Oncodesign
2.6.1 Business Overview
2.6.2 Patient Derived Xenograft/PDX Models Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Oncodesign Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.7 Horizon Discovery
2.7.1 Business Overview
2.7.2 Patient Derived Xenograft/PDX Models Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pharmatest Services
2.8.1 Business Overview
2.8.2 Patient Derived Xenograft/PDX Models Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hera Biolabs
2.9.1 Business Overview
2.9.2 Patient Derived Xenograft/PDX Models Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.10 EPO Berlin-Buch
2.10.1 Business Overview
2.10.2 Patient Derived Xenograft/PDX Models Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.11 Xentech
2.11.1 Business Overview
2.11.2 Patient Derived Xenograft/PDX Models Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Xentech Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
2.12 Urolead
2.12.1 Business Overview
2.12.2 Patient Derived Xenograft/PDX Models Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Urolead Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
3 Global Patient Derived Xenograft/PDX Models Market Competition, by Players
3.1 Global Patient Derived Xenograft/PDX Models Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Patient Derived Xenograft/PDX Models Players Market Share
3.2.2 Top 10 Patient Derived Xenograft/PDX Models Players Market Share
3.3 Market Competition Trend
4 Global Patient Derived Xenograft/PDX Models Market Size by Regions
4.1 Global Patient Derived Xenograft/PDX Models Revenue and Market Share by Regions
4.2 North America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
4.3 Europe Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
4.5 South America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
5 North America Patient Derived Xenograft/PDX Models Revenue by Countries
5.1 North America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
5.2 USA Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
5.3 Canada Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
5.4 Mexico Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
6 Europe Patient Derived Xenograft/PDX Models Revenue by Countries
6.1 Europe Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
6.2 Germany Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
6.3 UK Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
6.4 France Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
6.5 Russia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
6.6 Italy Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue by Countries
7.1 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
7.2 China Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
7.3 Japan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
7.4 Korea Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
7.5 India Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
8 South America Patient Derived Xenograft/PDX Models Revenue by Countries
8.1 South America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
8.2 Brazil Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
8.3 Argentina Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
8.4 Colombia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Patient Derived Xenograft/PDX Models by Countries
9.1 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
9.2 Saudi Arabia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
9.3 UAE Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
9.4 Egypt Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
9.5 Nigeria Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
9.6 South Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
10 Global Patient Derived Xenograft/PDX Models Market Segment by Type
10.1 Global Patient Derived Xenograft/PDX Models Revenue and Market Share by Type (2013-2018)
10.2 Global Patient Derived Xenograft/PDX Models Market Forecast by Type (2018-2023)
10.3 Mice Models Revenue Growth Rate (2013-2023)
10.4 Rat Models Revenue Growth Rate (2013-2023)
11 Global Patient Derived Xenograft/PDX Models Market Segment by Application
11.1 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2013-2018)
11.2 Patient Derived Xenograft/PDX Models Market Forecast by Application (2018-2023)
11.3 Pre-clinical Drug Development and Basic Cancer Research Revenue Growth (2013-2018)
11.4 Biomarker Analysis Revenue Growth (2013-2018)
12 Global Patient Derived Xenograft/PDX Models Market Size Forecast (2018-2023)
12.1 Global Patient Derived Xenograft/PDX Models Market Size Forecast (2018-2023)
12.2 Global Patient Derived Xenograft/PDX Models Market Forecast by Regions (2018-2023)
12.3 North America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
12.4 Europe Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
12.6 South America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Patient Derived Xenograft/PDX Models Picture
Table Product Specifications of Patient Derived Xenograft/PDX Models
Table Global Patient Derived Xenograft/PDX Models and Revenue (Million ) Market Split by Product Type
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Types in 2017
Figure Mice Models Picture
Figure Rat Models Picture
Table Global Patient Derived Xenograft/PDX Models Revenue (Million ) by Application (2013-2023)
Figure Patient Derived Xenograft/PDX Models Revenue Market Share by Applications in 2017
Figure Pre-clinical Drug Development and Basic Cancer Research Picture
Figure Biomarker Analysis Picture
Table Global Market Patient Derived Xenograft/PDX Models Revenue (Million ) Comparison by Regions 2013-2023
Figure North America Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Figure Europe Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Figure South America Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Figure Global Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (2013-2023)
Table Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table Crown Bioscience Patient Derived Xenograft/PDX Models Type and Applications
Table Crown Bioscience Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table The Jackson Laboratory Basic Information, Manufacturing Base and Competitors
Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Type and Applications
Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Champions Oncology Basic Information, Manufacturing Base and Competitors
Table Champions Oncology Patient Derived Xenograft/PDX Models Type and Applications
Table Champions Oncology Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table Charles River Laboratories Patient Derived Xenograft/PDX Models Type and Applications
Table Charles River Laboratories Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table WuXi Apptec Basic Information, Manufacturing Base and Competitors
Table WuXi Apptec Patient Derived Xenograft/PDX Models Type and Applications
Table WuXi Apptec Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Oncodesign Basic Information, Manufacturing Base and Competitors
Table Oncodesign Patient Derived Xenograft/PDX Models Type and Applications
Table Oncodesign Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Discovery Basic Information, Manufacturing Base and Competitors
Table Horizon Discovery Patient Derived Xenograft/PDX Models Type and Applications
Table Horizon Discovery Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Pharmatest Services Basic Information, Manufacturing Base and Competitors
Table Pharmatest Services Patient Derived Xenograft/PDX Models Type and Applications
Table Pharmatest Services Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Hera Biolabs Basic Information, Manufacturing Base and Competitors
Table Hera Biolabs Patient Derived Xenograft/PDX Models Type and Applications
Table Hera Biolabs Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table EPO Berlin-Buch Basic Information, Manufacturing Base and Competitors
Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Type and Applications
Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Xentech Basic Information, Manufacturing Base and Competitors
Table Xentech Patient Derived Xenograft/PDX Models Type and Applications
Table Xentech Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Urolead Basic Information, Manufacturing Base and Competitors
Table Urolead Patient Derived Xenograft/PDX Models Type and Applications
Table Urolead Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)
Table Global Patient Derived Xenograft/PDX Models Revenue (Million ) by Players (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue Share by Players (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Players in 2016
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Players in 2017
Figure Global Top 5 Players Patient Derived Xenograft/PDX Models Revenue Market Share in 2017
Figure Global Top 10 Players Patient Derived Xenograft/PDX Models Revenue Market Share in 2017
Figure Global Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate (%) (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue (Million ) by Regions (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions in 2017
Figure North America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Europe Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure South America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table North America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
Table North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017
Figure USA Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Canada Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Mexico Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table Europe Patient Derived Xenograft/PDX Models Revenue (Million ) by Countries (2013-2018)
Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017
Figure Germany Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure UK Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure France Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Russia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Italy Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million ) by Countries (2013-2018)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017
Figure China Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Japan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Korea Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure India Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table South America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)
Table South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017
Figure Brazil Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Argentina Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Colombia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Patient Derived Xenograft/PDX Models Revenue (Million ) by Countries (2013-2018)
Table Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017
Figure Saudi Arabia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure UAE Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Egypt Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure Nigeria Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Figure South Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue (Million ) by Type (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue Share by Type (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Type (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Type in 2017
Table Global Patient Derived Xenograft/PDX Models Revenue Forecast by Type (2018-2023)
Figure Global Patient Derived Xenograft/PDX Models Market Share Forecast by Type (2018-2023)
Figure Global Mice Models Revenue Growth Rate (2013-2018)
Figure Global Rat Models Revenue Growth Rate (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue by Application (2013-2018)
Table Global Patient Derived Xenograft/PDX Models Revenue Share by Application (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Application (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Application in 2017
Table Global Patient Derived Xenograft/PDX Models Revenue Forecast by Application (2018-2023)
Figure Global Patient Derived Xenograft/PDX Models Market Share Forecast by Application (2018-2023)
Figure Global Pre-clinical Drug Development and Basic Cancer Research Revenue Growth Rate (2013-2018)
Figure Global Biomarker Analysis Revenue Growth Rate (2013-2018)
Figure Global Patient Derived Xenograft/PDX Models Revenue (Million ) and Growth Rate Forecast (2018 -2023)
Table Global Patient Derived Xenograft/PDX Models Revenue (Million ) Forecast by Regions (2018-2023)
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
Figure South America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)
Companies
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead
- PRICE
-
$3480$6960